Lorcaserin Dosage
Applies to the following strengths: 10 mg; 20 mg
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Weight Loss
10 mg orally twice per day
Comments: Response to therapy should be evaluated by week 12. If a patient has not lost at least 5% of baseline body weight, discontinue this drug as it is unlikely the patient will achieve and sustain clinically meaningful weight loss with continued treatment.
Use: Adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) OR 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes mellitus, or dyslipidemia.
Renal Dose Adjustments
- Mild renal impairment (CrCl 50 to 80 mL/min): No adjustment recommended.
- Moderate renal impairment (CrCl 30 to 50 mL/min): Use with caution.
- Severe renal impairment (CrCl less than 30 mL/min) or end stage renal disease: Not recommended.
Liver Dose Adjustments
- Mild liver impairment (Child-Pugh 5 to 6): No adjustment recommended.
- Moderate liver impairment (Child-Pugh 7 to 9): No adjustment recommended.
- Severe liver impairment (Child-Pugh greater than 9): Not recommended.
Precautions
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
US Controlled Substance: Schedule IV
Dialysis
- Hemodialysis: This drug is not eliminated to a therapeutically significant degree by hemodialysis; no dose adjustment guidelines have been reported.
- Peritoneal Dialysis: Data not available.
Other Comments
Administration Advice:
- Do not exceed recommended dose.
- Take with or without food.
General:
- The effect of this drug on cardiovascular morbidity and mortality has not been established.
- The safety and effectiveness of this drug in combination with other weight loss products, including prescription and over-the-counter drugs and herbal preparations, have not been established.
- This drug's ability to produce hallucinations, euphoria, and positive subjective responses at supratherapeutic doses suggest this drug may produce psychic dependence. There are no controlled data in animal or human studies that evaluate dependence.
Monitoring:
Endocrine: Blood glucose levels (prior to and during treatment in type 2 diabetic patients), prolactin (when prolactin excess is suspected)
Hematologic: CBC (periodically during treatment)
Nervous: Serotonin syndrome/Neuroleptic Malignant Syndrome-like signs and symptoms
Psychiatric: Depression, suicidal thoughts or behavior, unusual changes in mood or behavior
More about lorcaserin
- Check interactions
- Compare alternatives
- Reviews (939)
- Side effects
- During pregnancy
- Drug class: anorexiants
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mounjaro
Mounjaro (tirzepatide) is FDA-approved to manage type 2 diabetes in adults. It lowers blood sugar ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Saxenda
Saxenda (liraglutide) injection is used for weight loss in obese or overweight patients. Includes ...
Alli
alli blocks the absorption of some of the fat that you eat and is used to treat obesity. Learn ...
Tirzepatide
Tirzepatide is a once-weekly injection used for weight loss, sleep apnea, and type 2 diabetes ...
Phentermine
Phentermine is an appetite suppressant used together with diet and exercise to treat obesity. Learn ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.